Paul R. Fonteyne, Director at Amylyx Pharmaceuticals, Inc. (AMLX), bought 3,947 shares at $19.00 ($75K) on 2022-01-06, disclosed to the SEC on 2022-01-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |